Skip to main content
. 2021 Mar 9;10(5):399–411. doi: 10.1002/psp4.12600

FIGURE 2.

FIGURE 2

Observed mean plasma pharmacokinetic profiles (red circles) versus population predictions (mean and 5/95% prediction intervals) following application of the reference (a) and the test (b) drug product. Predictions were generated leveraging dermal physiologically‐based pharmacokinetic models developed for Voltaren topical gel, 1% (reference) and its genetic (test)